Cargando…

Sjögren’s Syndrome Treatments in the Microbiome Era

Sjögren’s syndrome (SS) is a chronic autoimmune disease characterized by inflammatory cell infiltration of the salivary and lacrimal glands, resulting in acinar epithelial cell atrophy, cell death, and loss of exocrine function. At least half of SS patients develop extraglandular inflammatory diseas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Freguia, Christian Furlan, Pascual, David W., Fanger, Gary R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270702/ https://www.ncbi.nlm.nih.gov/pubmed/37323129 http://dx.doi.org/10.20900/agmr20230004

Ejemplares similares

Treatment with a Lactococcus lactis that chromosomally express E. coli cfaI mitigates salivary flow loss in a Sjögren’s syndrome-like disease
por: Akgul, Ali, et al.
Publicado: (2023)

Lactococcus lactis Delivery of Surface Layer Protein A Protects Mice from Colitis by Re-Setting Host Immune Repertoire
por: Arukha, Ananta Prasad, et al.
Publicado: (2021)

A Glimpse Into the Microbiome of Sjögren’s Syndrome
por: Deng, Chuiwen, et al.
Publicado: (2022)

620. Oral β-Lactamase Therapies Prevent Microbiome Damage and Attenuate Antibiotic Resistance From IV and Oral Antibiotics in Large Animal Models of Antibiotic-Mediated Gut Dysbiosis
por: Connelly, Sheila, et al.
Publicado: (2018)

673. Novel Delayed-Release Formulation of an Oral β-Lactamase Prevents Gut Microbiome Damage and Attenuates Antibiotic Resistance Caused by Oral Amoxicillin/Clavulanate without Interfering with Amoxicillin Systemic Absorption in Dogs
por: Connelly, Sheila, et al.
Publicado: (2019)

Altered Mucosal Microbiome Diversity and Disease Severity in Sjögren Syndrome
por: de Paiva, Cintia S., et al.
Publicado: (2016)

Current insights into the relationship between the gut microbiome and Sjögren’s syndrome
por: van der Meulen, Taco A., et al.
Publicado: (2020)

Tear film microbiome in Sjogren’s and non-Sjogren’s aqueous deficiency dry eye
por: Pal, Spandita, et al.
Publicado: (2023)

Current Insights in Microbiome Shifts in Sjogren’s Syndrome and Possible Therapeutic Interventions
por: Tsigalou, Christina, et al.
Publicado: (2018)

Correlation Between Salivary Microbiome of Parotid Glands and Clinical Features in Primary Sjögren’s Syndrome and Non-Sjögren’s Sicca Subjects
por: Kim, Donghyun, et al.
Publicado: (2022)

Primary Sjogren’s Syndrome Associated With Treatment-Resistant Obsessive–Compulsive Disorder
por: Ong, Lawrence T. C., et al.
Publicado: (2017)

Editorial: Gut microbiome, metabolites, and immune response in lupus, rheumatoid arthritis, and Sjögren syndrome
por: Zhao, Lidan, et al.
Publicado: (2023)

Tissue factor-PAR2 signaling promotes diet-induced obesity and adipose inflammation
por: Badeanlou, Leylla, et al.
Publicado: (2011)

Analysis of Conjunctival Sac Microbiome in Dry Eye Patients With and Without Sjögren's Syndrome
por: Song, Hang, et al.
Publicado: (2022)

Mycophenolate for the Treatment of Primary Sjögren’s Syndrome
por: Chen, Weiqian, et al.
Publicado: (2020)

Sjögren’s syndrome
por: André, Fiona, et al.
Publicado: (2022)

Karl Gustaf Torsten Sjögren and Sjögren-Larsson syndrome
por: Aboud, Khalid Al, et al.
Publicado: (2011)

Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis
por: Nezos, Adrianos, et al.
Publicado: (2015)

The Future of Biologic Agents in the Treatment of Sjögren’s Syndrome
por: Meijer, Jiska M., et al.
Publicado: (2007)

Autonomic Abnormalities in Patients With Primary Sjogren’s Syndrome – Preliminary Results
por: Brunetta, Enrico, et al.
Publicado: (2019)

Frontal fibrosing alopecia in association with Sjögren's syndrome: more than a simple coincidence
por: Furlan, Karina Colossi, et al.
Publicado: (2016)

Pathogenesis and treatment of Sjogren’s syndrome: Review and update
por: Zhan, Qipeng, et al.
Publicado: (2023)

T Cells Subsets in the Immunopathology and Treatment of Sjogren’s Syndrome
por: Ríos-Ríos, William de Jesús, et al.
Publicado: (2020)

Metformin as a Treatment Strategy for Sjögren’s Syndrome
por: Kim, Joa, et al.
Publicado: (2021)

The epidemiology of Sjögren’s syndrome
por: Patel, Ruchika, et al.
Publicado: (2014)

IL-21 and Sjögren's syndrome
por: Scofield, R Hal
Publicado: (2011)

Imaging in Primary Sjögren’s Syndrome
por: van Ginkel, Martha S., et al.
Publicado: (2020)

Neuro-Sjögren: Peripheral Neuropathy With Limb Weakness in Sjögren's Syndrome
por: Seeliger, Tabea, et al.
Publicado: (2019)

ACPA-positive primary Sjögren's syndrome: true primary or rheumatoid arthritis-associated Sjögren's syndrome?
por: Payet, J, et al.
Publicado: (2015)

Lady Windermere syndrome in Sjögren’s syndrome
por: Pan, Yu-Ling, et al.
Publicado: (2018)

Dental Implants in Sjögren Syndrome
por: Daneshparvar, Hamidreza, et al.
Publicado: (2020)

Sjögren's syndrome with acute renal failure.
por: Kwon, Y. J., et al.
Publicado: (1998)

The lived experience of Sjögren’s Syndrome
por: Ngo, Di Ying J., et al.
Publicado: (2016)

Advances in Pathogenesis of Sjögren's Syndrome
por: Tian, Yao, et al.
Publicado: (2021)

Managing Sjögren’s Syndrome and non-Sjögren Syndrome dry eye with anti-inflammatory therapy
por: Coursey, Terry G, et al.
Publicado: (2014)

Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren’s Syndrome
por: Soyfoo, Muhammad Shahnawaz, et al.
Publicado: (2018)

Innate Immunity and Biological Therapies for the Treatment of Sjögren’s Syndrome
por: Srivastava, Amrita, et al.
Publicado: (2020)

Fatigue in Sjögren's Syndrome: A Search for Biomarkers and Treatment Targets
por: Bodewes, Iris L. A., et al.
Publicado: (2019)

Renal Disease in Primary Sjögren’s Syndrome
por: Aiyegbusi, Oshorenua, et al.
Publicado: (2020)

Comparison of Treatment Modalities for Dry Eye in Primary Sjögren’s Syndrome
por: Ahn, Hyunmin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_f2n6sv2jjp3mp858luvo1f4o07